Molecular and cytogenetic investigations of the fragile X Region including the frax A and frax E CGG trinucleotide repeat sequences in families multiplex for autism and related phenotypes

Human Heredity

Volumn 47, Issue 5, 1997, Pages 254-262

  Gurling, H M D ^a   Bolton, P F ^c   Vincent, J ^a   Melmer, J ^a   Melmer, G ^a   Rutter, M ^b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Autism; Fragile X; Genetics

Indexed keywords

ARTICLE; AUTISM; CHROMOSOME XQ; CYTOGENETICS; DNA METHYLATION; FAMILY; FRAGILE X SYNDROME; HUMAN; MOLECULAR GENETICS; PHENOTYPE; POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; TRINUCLEOTIDE REPEAT;

AUTISTIC DISORDER; BLOTTING, SOUTHERN; DNA TRANSPOSABLE ELEMENTS; FAMILY HEALTH; FEMALE; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; HUMANS; MALE; METHYLATION; MUTATION; NERVE TISSUE PROTEINS; PEDIGREE; PHENOTYPE; POLYMERASE CHAIN REACTION; RNA-BINDING PROTEINS; TRINUCLEOTIDE REPEAT EXPANSION; TRINUCLEOTIDE REPEATS;

EID: 0030864713     PISSN: 00015652     EISSN: 14230062     Source Type: Journal    
DOI: 10.1159/000154421     Document Type: Article

References (20)

1. Cartwright GE, Edwards CQ, Kravitz K, Skolnick M, Amos DB, Johnson A, Bushjaer L: Hereditary hemochromatosis: phenotypic expression of the disease. N Engl J Med 1979:301:175-179.
2. Edwards CQ, Cartwright GE, Skolnick MH, Amos DB: Homozygosity for hemochromatosis: Clinical manifestations. Ann Intern Med 1980: 93:519-525.
3. Björn-Rasmussen E: Iron absorption: Present knowledge and controversies. Lancet 1983:i:914-916.
4. Simon M, Bourel M, Fauchet R, Genetel B: Associations of HLA-A3 and HLA-BI4 antigens with idiopathic haemochromatosis. Gut 1976:17:332-334.
5. Milman N, Grandal N, Nielsen LS, Fenger K: HLA determinants in 70 Danish patients with idiopathic haemochromatosis. Clin Genet 1988: 33:286-292.
6. Ritter B, Säfwenberg J, Olsson KS: HLA as a marker of hemochromatosis in Sweden. Ilum Genet 1984:68: 62-66.
7. Jazwinska EC, Lee SC, Webb SI, Halliday JW, Powell LW: Localization of the hemochromatosis gene close to D6S105. Am J Hum Genet 1993:53:347-352.
8. Feder JN, Gnirke A, Thomas W, Tsuehihashi Z, Ruddy DA, Basava A, Dormishian F, Domingo R Jr., Ellis MC, Fullan A, Hinton LM, Jones NL, Kimrnel BE, Mapa FA, McClelland E. Meyer NC, Mintier GA, Moeller N, Moore T, Morikang E, Prass CE, Quintana L, Starnes SM, Schatzman RC, Brunke KJ, Dravna DT, Risch NJ, Bacon BR, Wolff RK: A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nature Genet 1996;13:399-408.
9. Mercier B, Mura C, Ferec C, Bodmer JG, Parham P, Albert ED, Marsh SGE: Putting a hold on HLA-H’. Nature Genet 1997:15: 234-235.
10. Jouanolle AM. Gaudou G, Jezequel P, Bloyan M, Campion ML, Yaonang J, Mosser J, Fergelot P, Chauvel B, Bouric P, Cam G, Andrieux N, Giequel I, Le Gall J-Y, David V: Haemochromatosis and HLA. Nature Genet 1996:14:251-252.
11. Jazwinska EC, Cullen LM, Busfield F, Pepper WR, Webb SI, Powell LW, Morris CP, Walsh TP: Haemochromatosis and HLA. Nature Genet 1996:14:249-250.
12. De Brekkelecr M: A prevalence and fertility study of haemochromatosis in Saguenay-Lac-Saint-Jean. Ann Hum Biol 1993:20:501-505.
13. Olsson KS, Ritter B, Rosen U, Hcedman PA, Stangard F: Prevalence of iron overload in central Sweden. Acta Med Stand 1983:213: 145-150.
14. Edwards CQ, Griffen LM, Goldgar D, Drummond C, Skolnick HM, Kushner JP: Prevalence of hemochromatosis among 11 065 presumably healthy blood donors. N Engl J Med 1988:318:1355-1362.
15. Beaumont C, Simon M, Fauchel R, Hespel J-P, Brissot P, Genetet B, Bourel M: Serum ferritin as a possible marker of the haemochromatosis allele. N Engl J Med 1979:301:169-174.
16. Mac Sween RNM, Scott AR: Hepatic cirrhosis: A clinicopathological review of 520 cases. J Clin Pathol 1973;26:936-942.
17. Karlsson M, Ikkala E, Rcunanen A, Takkunen H, Vuori E, Makinen J: Prevalence of haemochromatosis in Finland. Acta Med Scand 1988:224: 209-210.
18. Sjalander A, Birgander R, Saha N, Beckman L, Beckman G: p53 polymorphisms and haplotypes show distinct differences between major ethnic groups. Hum Hered 1996:46: 41-48.
19. Stevens R: Iron and the risk of cancer. Oncol Tumor Pharmacother 1990:7:177-181.
20. Weinberg ED: The role of iron in cancer. Eur J Cancer Prey 1996:5: 19-36.